Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Limiting HCDR3 diversity abrogates the antibody response to the bacterial polysaccharide α 1→3 Dextran (45.20)

Tamer Mahmoud, Harry Schroeder and John Kearney
J Immunol April 1, 2011, 186 (1 Supplement) 45.20;
Tamer Mahmoud
1Microbiology, University of Alabama at Birmingham, Birmingham, AL
2Faculty of Pharmacy, Cairo University, Cairo, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry Schroeder
1Microbiology, University of Alabama at Birmingham, Birmingham, AL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Kearney
1Microbiology, University of Alabama at Birmingham, Birmingham, AL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Anti-polysaccharide antibody responses in mice are often oligoclonal and the mechanisms involved in the production and subsequent antigen-driven selection of these clones are poorly understood. In this study, we investigated the α 1→3 Dextran (DEX) antibody response of gene-targeted mice limited to the usage of one DH gene segment (D-limited mice). We show that the DEX-specific antibody response is broadly comparable in D-limited mice to that of wild type BALB/c (WT) mice. D-limited mice forced to use DH reading frame 2 (ΔD-DµFS) showed both a higher total anti-DEX antibody response compared to other D-limited mice and the dominant DEX-specific J558 idiotype (Id) was higher compared to all mouse groups. Nucleotide sequencing of HCDR3s of DEX-specific plasmablasts showed that ΔD-DµFS mice generated 70% of clones similar to those from WT, including the predominant adult molecularly-determined clone J558. All three D-limited mouse groups showed a higher frequency of unusual DH-less HCDR3 regions compared to WT suggesting extensive junctional modification mediated by TdT. D-limited mice on TdT-deficient background failed to elicit a response to DEX. Overall, these data show that TdT activity is required to compensate for constraints on HCDR3 diversity for the generation of a normal anti-DEX antibody response by D-limited mice.

  • Copyright © 2011 by The American Association of Immunologists, Inc.
Previous
Back to top

In this issue

The Journal of Immunology
Vol. 186, Issue 1 Supplement
April 2011
  • Table of Contents
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Limiting HCDR3 diversity abrogates the antibody response to the bacterial polysaccharide α 1→3 Dextran (45.20)
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Limiting HCDR3 diversity abrogates the antibody response to the bacterial polysaccharide α 1→3 Dextran (45.20)
Tamer Mahmoud, Harry Schroeder, John Kearney
The Journal of Immunology April 1, 2011, 186 (1 Supplement) 45.20;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Limiting HCDR3 diversity abrogates the antibody response to the bacterial polysaccharide α 1→3 Dextran (45.20)
Tamer Mahmoud, Harry Schroeder, John Kearney
The Journal of Immunology April 1, 2011, 186 (1 Supplement) 45.20;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

  • CD28: a novel negative regulator of plasma cell function and survival. (45.16)
  • Prostaglandin E2 upregulates p53 mRNA and protein within activated human B lymphocytes (45.17)
  • Dendritic cells express possible ligand(s) for CD38 (45.13)
Show more B Cell Generation and Function

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606